Author

G. González-Iglesias

BioCruces Health research InstituteORCID 0000-0002-7220-4243Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Aina AntoniD· 1 shared Andrea López‐MartíneziD· 1 shared E. Albiasu-Arteta· 1 shared Estibaliz Ruiz-del-YerroiD· 1 shared Federico GonzãleziD· 1 shared Iker Garcia-Jimenez· 1 shared Irene Larrañaga-AiestaraniD· 1 shared Javier Poyatos‐GarcíaiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Aina AntonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Duchenne Muscular Dystrophy Cell Culture Models Created By CRISPR/Cas9 Gene Editing And Their Application To Drug Screening

Patricia Soblechero‐Martín, E. Albiasu-Arteta, Aina Anton, Laura de la Puente Ovejero, Iker Garcia-Jimenez, G. González-Iglesias, Irene Larrañaga-Aiestaran, Andrea López‐Martínez, Javier Poyatos‐García, Estibaliz Ruiz-del-Yerro, Federico Gonzãlez, Virginia Arechavala‐Gomeza

The paper describes CRISPR/Cas9-generated Duchenne muscular dystrophy cell models for drug screening, showing successful exon deletion and utrophin upregulation.

Scientific Reports · Sep 14, 2021Peer-reviewedNeuroscience